FDA Inspection 1173929 — QYK - Garen Grove Western
The FDA completed an inspection of QYK - Garen Grove Western on Jul 1, 2022 in Garden Grove, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Garden Grove, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1876 | 21 CFR 211.180(b) | Record maintenance 1 year (except exempt OTC) |
| 1883 | 21 CFR 211.165(a) | Testing and release for distribution |
| 3559 | 21 CFR 211.56(a) | Sanitation--buildings not clean, free of infestation |